A. Barnadas

Increased signalling of EGFR and IGF1R, and deregulation of PTEN/PI3K/Akt pathway are related with trastuzumab resistance in HER2 breast carcinomas

Alberto Gallardo, Enrique Lerma, Daniel Escuín et al. · British Journal of Cancer · 2012 · 230 citations · Full text

Src, a potential target for overcoming trastuzumab resistance in HER2-positive breast carcinoma

Gloria Peiró, Fernando Ortiz-Martínez, Alberto Gallardo et al. · British Journal of Cancer · 2014 · 90 citations · Full text

Gene expression signatures and molecular markers associated with clinical outcome in locally advanced head and neck carcinoma

Miguel Ángel Pavón, Matilde Parreño, Marta Tellez Gabriel et al. · Carcinogenesis · 2012 · 35 citations · Full text

Subtype 1, Molecular Markers, Tumor Recurrence +21

Correlation between immune-related adverse events (irAEs) and efficacy in patients with solid tumors treated with immune-checkpoints inhibitors (ICIs).

Mariona Riudavets, Andrés Barba, Pablo Maroto et al. · Journal of Clinical Oncology · 2018 · 32 citations

Solid Tumors, Cancer Management, Immunology +19

Anti‐Ri‐associated paraneoplastic neurologic disorder without opsoclonus in a patient with breast cancer

Domingo Escudero, A. Barnadas, Maria Sanz-Codina et al. · Neurology · 1993 · 26 citations

Neuro-oncology, Endocrine Oncology, Surgical Oncology +11